ロード中...
IMT-05 PHASE III RANDOMIZED CLINICAL TRIAL OF AFTV FOR NEWLY DIAGNOSED GLIOBLASTOMA
BACKGROUND: The highly fatal glioblastoma has an extremely poor prognosis and development of a new treatment is desired. Local treatment is limited due to its high invasiveness, and immunotherapy utilizing self-immune mechanism is theoretically expected. An autologous formalin-fixed tumor vaccine (A...
保存先:
| 出版年: | Neurooncol Adv |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7213209/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.079 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|